Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation.

作者: Thierry Guillaume , Daniel B. Rubinstein , Michel Symann

DOI: 10.1182/BLOOD.V92.5.1471

关键词:

摘要: APPROXIMATELY 10,000 autologous hematopoietic stem cell (HSC) transplants are performed worldwide each year for malignant diseases.[1][1] Results of randomized trials in recent years suggest that high-dose chemotherapy followed by infusion HSCs can offer prolonged disease-free survival

参考文章(245)
LM Schuchter, JR Wingard, S Piantadosi, WH Burns, GW Santos, R Saral, Herpes zoster infection after autologous bone marrow transplantation Blood. ,vol. 74, pp. 1424- 1427 ,(1989) , 10.1182/BLOOD.V74.4.1424.1424
S Dubinett, J S Economou, J Glaspy, L H Butterfield, W H McBride, S M Kiertscher, J F Arthur, M D Roth, R Lau, L A Bui, A comparison of gene transfer methods in human dendritic cells Cancer Gene Therapy. ,vol. 4, pp. 17- 25 ,(1997)
Collis C, Cunningham Jm, Gottlieb Dj, Smith Op, Gandhi L, Hamon, Prentice Hg, Macdonald Id, Gilmore M, Immunotherapy with interleukin 2 after ABMT in AML Bone Marrow Transplantation. ,vol. 11, pp. 399- 401 ,(1993)
Stanley R. Riddell, Philip D. Greenberg, Cellular adoptive immunotherapy after bone marrow transplantation. Cancer treatment and research. ,vol. 76, pp. 337- 369 ,(1995) , 10.1007/978-1-4615-2013-9_16
H. K. Müller-Hermelink, R. Storb, G. E. Sale, B. Borisch, Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients. American Journal of Pathology. ,vol. 129, pp. 242- 256 ,(1987)
E Bolotin, M Smogorzewska, S Smith, M Widmer, K Weinberg, Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood. ,vol. 88, pp. 1887- 1894 ,(1996) , 10.1182/BLOOD.V88.5.1887.BLOODJOURNAL8851887